home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

120 rows where has_cryoEM = 1, has_known_aptamer = 1 and surface_class = "A_surface" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: aptamer_count_pubmed

tier 3

  • Tier 1 87
  • Tier 1.5 32
  • Positive Control 1

in_cev_map 2

  • 0 60
  • 1 60

has_activation_state_pdb_pair 2

  • 0 119
  • 1 1

surface_class 1

  • A_surface · 120 ✖

has_structure 1

  • 1 120

has_known_aptamer 1

  • 1 · 120 ✖

has_cryoEM 1

  • 1 · 120 ✖
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P21359 NF1 Neurofibromin Tier 1.5 0.965 1 A_surface 26 87.19 1 0     1 2 32980430, 22617876 1 neurofibromatosis type 1 0.8844735398780649
P04839 CYBB NADPH oxidase 2 Tier 1 0.959 1 A_surface 6 90.25 1 0     1 2 24635113 1 chronic granulomatous disease 0.8633132852459866
P29965 CD40LG CD40 ligand Tier 1 0.954 1 A_surface 8 82.62 1 0     1 6 37331977, 36203210, 26504624 1 hyper-IgM syndrome type 1 0.8451678829647167
P37173 TGFBR2 TGF-beta receptor type-2 Tier 1 0.952 1 A_surface 22 81.0 1 0     1 8 32452828, 30595527, 29522674, 29375127, 26284552, 23999222, 22899759, 11856769 1 Loeys-Dietz syndrome 0.8390072008866913
P19438 TNFRSF1A Tumor necrosis factor receptor superfamily member 1A Tier 1 0.951 1 A_surface 13 71.38 1 0     1 1 35197258 1 TNF receptor 1-associated periodic fever syndrome 0.8352778213184682
P06744 GPI Glucose-6-phosphate isomerase Tier 1 0.949 1 A_surface 13 97.94 1 0     1 19 41911185, 41329468, 41232387, 35821507, 34953205, 32730952, 29501157, 27419372, 25919296, 25483705, 24334484, 23656757, 23578283, 23018995, 22116094, 20967861, 17574575, 27380815 1 hemolytic anemia due to glucophosphate isomerase deficiency 0.8306909118751346
P36897 TGFBR1 TGF-beta receptor type-1 Tier 1 0.948 1 A_surface 44 84.19 1 0     1 1 41089000 1 Loeys-Dietz syndrome 1 0.8275292516338373
P22607 FGFR3 Fibroblast growth factor receptor 3 Tier 1 0.948 1 A_surface 13 74.19 1 0     1 6 38569854, 37704353, 34864168, 33952673, 31357131 1 achondroplasia 0.8270702096931246
P04156 PRNP Major prion protein Tier 1 0.947 1 A_surface 70 64.19 1 0     1 2 39556313, 34067472 1 Gerstmann-Straussler-Scheinker syndrome 0.8246149684620239
P05106 ITGB3 Integrin beta-3 Positive Control 0.946 1 A_surface 123 87.0 1 1 8T2U 8T2V 1 2 22133781, 23544955 1 Glanzmann thrombasthenia 1 0.8208115968652424
P08069 IGF1R Insulin-like growth factor 1 receptor Tier 1 0.945 1 A_surface 46 78.0 1 0     1 10 40997970, 39263947, 33410883, 30041514, 23373648, 16019422, 15231297 1 growth delay due to insulin-like growth factor I resistance 0.8166352227841136
P16234 PDGFRA Platelet-derived growth factor receptor alpha Tier 1.5 0.945 1 A_surface 14 72.69 1 0     1 4 33334063, 32127469, 28010895, 30594071 1 gastrointestinal stromal tumor 0.8167494524079806
Q13563 PKD2 Polycystin-2 Tier 1 0.943 1 A_surface 31 70.12 1 0     1 3 41315228, 36126144 1 polycystic kidney disease 2 0.810960823768978
P58335 ANTXR2 Anthrax toxin receptor 2 Tier 1 0.941 1 A_surface 14 71.81 1 0     1 4 41503480, 41083485, 41020397, 40313273 1 hyaline fibromatosis syndrome 0.8028849863986661
P61073 CXCR4 C-X-C chemokine receptor type 4 Tier 1 0.94 1 A_surface 33 82.25 1 0     1 17 40671676, 40401615, 39865939, 39778270, 37052638, 35157940, 33739080, 31737891, 31267721, 31097627, 28670693, 26265085, 25329893, 22811524, 22376154, 12498773, 41543187 1 WHIM syndrome 0.8009225456235435
P15529 CD46 Membrane cofactor protein Tier 1.5 0.934 1 A_surface 7 82.12 1 0     1 9 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 1 atypical hemolytic-uremic syndrome with MCP/CD46 anomaly 0.7798469882597787
P13987 CD59 CD59 glycoprotein Tier 1 0.932 1 A_surface 17 79.31 1 0     1 1 19915929 1 primary CD59 deficiency 0.7738276843579196
P02511 CRYAB Alpha-crystallin B chain Tier 1 0.925 1 A_surface 21 75.75 1 0     1 2 28720498, 23530262 1 myofibrillar myopathy 2 0.7505030087389963
Q14432 PDE3A cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A Tier 1 0.924 1 A_surface 9 60.25 1 0     1 1 34456709 1 Brachydactyly - arterial hypertension 0.7468849549430213
P25445 FAS Tumor necrosis factor receptor superfamily member 6 Tier 1.5 0.921 1 A_surface 7 77.88 1 0     1 17 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 1 autoimmune lymphoproliferative syndrome type 1 0.7377210386590284
P07204 THBD Thrombomodulin Tier 1 0.92 1 A_surface 13 78.62 1 0     1 5 41988704, 34708097, 28549218, 21526769, 7622501 1 thrombomodulin-related bleeding disorder 0.7323266135403641
Q9H244 P2RY12 P2Y purinoceptor 12 Tier 1 0.919 1 A_surface 5 84.44 1 0     1 2 32679592, 19509485 1 platelet-type bleeding disorder 8 0.7304079345653686
P08575 PTPRC Receptor-type tyrosine-protein phosphatase C Tier 1 0.916 1 A_surface 6 76.06 1 0     1 1 25251012 1 immunodeficiency 104 0.7200430416648742
Q9UNQ0 ABCG2 Broad substrate specificity ATP-binding cassette transporter ABCG2 Tier 1 0.915 1 A_surface 29 85.25 1 0     1 8 40873307, 36807620, 35544739, 33833512, 31180052, 31085078, 26176230, 24319544 1 gout 0.7158028003520317
P13612 ITGA4 Integrin alpha-4 Tier 1 0.914 1 A_surface 7 84.44 1 0     1 3 30065768, 28670693, 26504766 1 Crohn's disease 0.7134551179424343
O75581 LRP6 Low-density lipoprotein receptor-related protein 6 Tier 1 0.911 1 A_surface 27 79.19 1 0     1 5 42031715, 37175248, 18673242 1 tooth agenesis, selective, 7 0.7022725510765017
P40189 IL6ST Interleukin-6 receptor subunit beta Tier 1 0.911 1 A_surface 20 74.62 1 0     1 2 39571081, 22258147 1 Autosomal recessive hyper-IgE syndrome 0.7027634038262931
Q15303 ERBB4 Receptor tyrosine-protein kinase erbB-4 Tier 1 0.903 1 A_surface 14 73.12 1 0     1 3 32592467, 30697465, 23990977 1 non-small cell lung carcinoma 0.6754899662390331
O15455 TLR3 Toll-like receptor 3 Tier 1 0.899 1 A_surface 20 90.62 1 0     1 7 26018150, 25528762, 17150912, 17150911 1 Herpetic encephalitis 0.6617401048830444
P07550 ADRB2 Beta-2 adrenergic receptor Tier 1 0.89 1 A_surface 100 79.12 1 0     1 2 41637639, 32376022 1 asthma 0.634300392456126
P11836 MS4A1 B-lymphocyte antigen CD20 Tier 1 0.888 1 A_surface 10 70.5 1 0     1 2 39865939, 29561802 1 chronic lymphocytic leukemia 0.6275806230802832
P02786 TFRC Transferrin receptor protein 1 Tier 1.5 0.887 1 A_surface 22 86.69 1 0     1 3 39831311, 29046922, 32527800 1 TFRC-related combined immunodeficiency 0.623449899069336
P01133 EGF Pro-epidermal growth factor Tier 1 0.886 1 A_surface 13 70.31 1 0     1 34 41906877, 41873087, 41693575, 39408993, 38904251, 38837175, 37423441, 35213974, 34893239, 32511241, 32200913, 31990606, 31004648, 30809312, 36132464, 28842588, 28029038, 27301192, 26504624, 25450403, 25261371, 24777583, 23531534, 23104156, 21999227, 21687663, 21576228, 19420593, 19063705, 20641927, 15037656, 13680379, 12842895, 12173045 1 cancer 0.6205045573389423
P60033 CD81 CD81 antigen Tier 1 0.885 1 A_surface 16 87.38 1 0     1 5 34505435, 32730952, 28959386, 23877701, 19997645 1 immunodeficiency, common variable, 6 0.6168240011812034
P51679 CCR4 C-C chemokine receptor type 4 Tier 1 0.862 1 A_surface 7 80.75 1 0     1 3 41518674, 39071952, 29103909 1 mycosis fungoides 0.5404546856597274
P05362 ICAM1 Intercellular adhesion molecule 1 Tier 1 0.859 1 A_surface 14 88.44 1 0     1 43 41699153, 40650261, 40539828, 40329889, 39154820, 37052638, 36508319, 35312740, 35212764, 34038704, 32884147, 32784904, 30697465, 30617526, 28631505, 27132231, 25582325, 25368913, 21147843, 20665479, 12714656, 11320245, 10097084, 9740353, 9200462, 8932275 1 neurodegenerative disease 0.5292405353144124
Q9NNX6 CD209 CD209 antigen Tier 1 0.858 1 A_surface 14 71.44 1 0     1 1 37017594 1 dengue disease 0.5252368050139995
O95858 TSPAN15 Tetraspanin-15 Tier 1 0.855 1 A_surface 3 87.56 1 0     1 1 37047289 1 venous thromboembolism 0.5182425801223098
P11717 IGF2R Cation-independent mannose-6-phosphate receptor Tier 1 0.853 1 A_surface 24 73.12 1 0     1 5 40554308, 39225423, 38059276, 36126144, 32040773 1 coronary artery disease 0.511249370339317
P15144 ANPEP Aminopeptidase N Tier 1 0.851 1 A_surface 15 93.06 1 0     1 1 33554306 1 cholelithiasis 0.5030146927270738
Q03405 PLAUR Urokinase plasminogen activator surface receptor Tier 1 0.845 1 A_surface 13 81.44 1 0     1 2 37533140 1 Abdominal Aortic Aneurysm 0.4819526979346149
Q07108 CD69 Early activation antigen CD69 Tier 1 0.844 1 A_surface 6 82.12 1 0     1 5 40448637, 39048513, 37110712, 32401486, 16331266 1 hypothyroidism 0.48068618377072814
Q92633 LPAR1 Lysophosphatidic acid receptor 1 Tier 1.5 0.843 1 A_surface 16 83.62 1 0     1 1 32065590 1 Epiretinal membrane 0.4757255248053499
P08174 CD55 Complement decay-accelerating factor Tier 1 0.84 1 A_surface 33 78.25 1 0     1 3 33398182, 19915929, 37566081 1 Protein-losing enteropathy 0.46728275901717004
P01871 IGHM Immunoglobulin heavy constant mu Tier 1 0.839 1 A_surface 30 85.44 1 0     1 3 33981223, 16825284 1 agammaglobulinemia 0.4624778576025314
O75084 FZD7 Frizzled-7 Tier 1 0.837 1 A_surface 13 83.19 1 0     1 2 18673242, 22363130 1 Abnormality of the skeletal system 0.45589181219776254
P01833 PIGR Polymeric immunoglobulin receptor Tier 1 0.833 1 A_surface 16 76.69 1 0     1 2 31640794, 29277631 1 clear cell renal carcinoma 0.44260204134234277
O60462 NRP2 Neuropilin-2 Tier 1 0.825 1 A_surface 16 78.62 1 0     1 2 41915779 1 esophageal disease 0.41662112843122434
P13569 CFTR Cystic fibrosis transmembrane conductance regulator Tier 1 0.824 1 A_surface 58 75.62 1 0     1 10 41148207, 31029337, 30595527, 22483890, 15657417 0 cystic fibrosis 0.9133535862571094
P02724 GYPA Glycophorin-A Tier 1 0.813 1 A_surface 16 59.41 1 0     1 1 40599565 1 malaria 0.37656968762740295

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 448.212ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target